ORIGINALS | |
Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain
Ángeles Castro, Pilar Díaz, Pere Domingo, Cristina García-Yubero, Juan E. Losa-García, Antonio Castro, Neus Vidal-Vilar , Susana Aceituno DOI: 10.7399/fh.13038 |
|
![]() |
|
Humanization Guide of the Spanish Society of Hospital Pharmacy for patients with inflammatory immune-mediated diseases
Ana María Álvarez-Díaz, Gabriel Mercadal-Orfila, Esther Ramírez-Herráiz, Joaquín Borrás-Blasco DOI: 10.7399/fh.13296 |
|
![]() |
|
REVISIONS | |
Processes implemented and activities carried out by the pharmacists during the COVID-19 pandemic: A scoping review (The article is not available in this language)
Pedro Amariles, Mauricio Monsalve, Mónica Rivera-Cadavid, Mauricio Ceballos, Mónica Ledezma-Morales, Andrea Salazar-Ospina DOI: 10.7399/fh.13146 |
|
![]() |
|
SPECIAL ARTICLE | |
Patient benefit as a goal of humanization
Manuel David Gil-Sierra, María del Pilar Briceño-Casado, Eduardo López-Briz DOI: 10.7399/fh.13171 |
|
![]() |
|
PROTOCOLO | |
Semaglutide versus GLP-1 agonists. Effectiveness, safety, and quality of life in patients with diabetes mellitus 2. The SEVERAL study
José Seijas-Amigo, Ángel Salgado-Barreira, Rosana Castelo-Domínguez, Mercedes Pereira-Pía, Moisés Rodríguez-Mañero, José Ramón González-Juanatey, en representación del grupo de estudio SEVERAL DOI: 10.7399/fh.13215 |
|
![]() |